| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 01/25/2012 | CN101856346B Medical application of coumaroyl spermidine type compounds or plant extracts thereof |
| 01/25/2012 | CN101797388B Matrix of suppository or paste medicine for treating prostatitis and preparation method thereof |
| 01/25/2012 | CN101152264B Medicament for treating prostate disease and urinary tract infection and method for preparing the same |
| 01/24/2012 | US8101650 Method for treating a immunology-related disease |
| 01/24/2012 | US8101599 Pharmaceutical composition containing anti-hypertensive agents |
| 01/24/2012 | CA2493644C Composition for promoting the proliferation of lactobacillus casei subsp. casei |
| 01/24/2012 | CA2462857C Angiotensin peptide-carrier conjugates and uses thereof |
| 01/24/2012 | CA2455227C Use of biologically active hiv-1 tat, fragments or derivates thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 01/24/2012 | CA2435687C Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells |
| 01/24/2012 | CA2402092C 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
| 01/24/2012 | CA2370763C Peptide epitopes recognized by disease promoting cd4+ t lymphocytes |
| 01/19/2012 | WO2012009475A1 Methods of treating cancer with inhibition of lysine-specific demethylase 1 |
| 01/19/2012 | WO2012008697A2 Orally administered agent for increasing sperm count |
| 01/19/2012 | WO2012008549A1 Heterocyclic ring compound |
| 01/19/2012 | WO2012008435A1 Biaryl amide derivative or pharmaceutically acceptable salt thereof |
| 01/19/2012 | WO2012006958A1 Amids substituted indazole derivativees as ploy(adp-ribose)polymerase inhibitors |
| 01/19/2012 | WO2012006865A1 Use of xanthoceras sorbifolia and xanthoceras sorbifolia extract in preparing medicaments for curing urinary incontinence or overactive bladder |
| 01/19/2012 | WO2012006864A1 Triterpenoid saponin compounds, preparation methods and uses thereof |
| 01/19/2012 | WO2011116262A3 Compositions and methods for diagnosing and treating urinary tract infections |
| 01/19/2012 | WO2011102655A3 Composition for percutaneous administration of tolterodine with reduced skin irritation |
| 01/19/2012 | US20120016035 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 01/19/2012 | US20120016023 Combination of Selected Opioids with Muscarine Antagonists for Treating Urinary Incontinence |
| 01/19/2012 | US20120016016 Methods and compositions for treating complications of diabetes and vascular diseases using flavones |
| 01/19/2012 | US20120015991 Polycyclic antagonists of lysophosphatidic acid receptors |
| 01/19/2012 | US20120015988 Sulfone Compounds Which Modulate The CB2 Receptor |
| 01/19/2012 | US20120015985 Methods of Administering Pirfenidone Therapy |
| 01/19/2012 | US20120015972 Indolizine derivative and use thereof for medical purposes |
| 01/19/2012 | US20120015966 Ppar active compounds |
| 01/19/2012 | US20120015954 Therapeutic agents useful for treating pain |
| 01/19/2012 | US20120015950 Carbamate derivatives of alkyl-heterocycles, preparation thereof and therapeutic use thereof |
| 01/19/2012 | US20120015949 Composition and method of decreasing renal ischemic damage |
| 01/19/2012 | US20120015944 Tetrazole-substituted arylamides as p2x3 and p2x2/3 antagonists |
| 01/19/2012 | US20120015928 Amido Compounds And Their Use As Pharmaceuticals |
| 01/19/2012 | US20120015913 Formulations of 14-EPI-Analogues of Vitamin D |
| 01/19/2012 | US20120015903 PHARMACEUTICAL COMPOSITION FOR INHIBITING INCREASE OF IgA |
| 01/19/2012 | US20120015901 Methods and preparations for protecting critically ill patients |
| 01/19/2012 | US20120015876 Conjugates of glp-1 agonists and uses thereof |
| 01/19/2012 | US20120015868 Metastin derivatives and use thereof |
| 01/19/2012 | US20120015024 Methods for treating tweak-related conditions |
| 01/19/2012 | US20120014979 Use of bcl6 inhibitors for treating autoimmune diseases |
| 01/19/2012 | US20120014920 Annexin and its use to treat inflammatory disorders |
| 01/19/2012 | CA2805110A1 Methods of treating hepatorenal syndrome and hepatic encephalopathy with thromboxane-a2 receptor antagonists |
| 01/18/2012 | EP2406260A1 Pyrrolo [2, 3-b]pyridine derivatives for the inhibition of raf kinases |
| 01/18/2012 | EP2406259A1 Pyrrolo [2, 3-b]pyridine derivatives for the inhibition of raf kinases |
| 01/18/2012 | EP2406252A1 Mineralocorticoid receptor antagonist and methods of use |
| 01/18/2012 | EP1637539B1 Pyrazole derivative, drug composition containing the same and production intermediate therefor |
| 01/18/2012 | EP1494730B1 Composition for hard tissue augmentation |
| 01/18/2012 | EP1456385B1 Growth hormone fusion protein |
| 01/18/2012 | CN102321080A Doxazosin mesylate V form crystal, and preparation method and usage thereof |
| 01/18/2012 | CN102321079A (-) doxazosin mesylate crystal VI as well as preparation method and application thereof |
| 01/18/2012 | CN102321078A Doxazosin mesylate III form crystal, and preparation method and usage thereof |
| 01/18/2012 | CN102321030A Heterocyclic inhibitors of MEK and methods of use thereof |
| 01/18/2012 | CN102321025A Process for the preparation of indazolyl ureas that inhibit vanilloid subtype 1 (VR1) receptors |
| 01/18/2012 | CN102319421A Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs |
| 01/18/2012 | CN102319418A Buserelin preparation and preparation method thereof |
| 01/18/2012 | CN102319376A Chinese herbal medicament for treating nephropathy |
| 01/18/2012 | CN102319371A Chinese medicinal composition for treating urinary system calculi |
| 01/18/2012 | CN102319299A Pharmaceutical composition for treating chronic renal failure and preparation method thereof |
| 01/18/2012 | CN102319280A Maca tablet and preparation method thereof |
| 01/18/2012 | CN102319275A Sunset abelmoschus flower extract, preparation and preparation method thereof |
| 01/18/2012 | CN102319267A Method for efficiently preparing bee pollen aqueous extract |
| 01/18/2012 | CN102319256A Application of porphyra polysaccharide in preparing treatment medicament or prevention health-care product of kidney diseases |
| 01/18/2012 | CN102319239A Application of ainsliaidimer A in preparing nucleolus transcription factor inhibitor medicament |
| 01/18/2012 | CN102319237A Application of quercetin in preparation of medicament for inhibiting NLRP3 inflammation body |
| 01/18/2012 | CN102319236A Application of polygonatum homoisoflavonoid compound in preparing product for treating diabetes mellitus and nephropathy |
| 01/18/2012 | CN102319228A Dutasteride liquid hard capsule and preparation method thereof |
| 01/18/2012 | CN102078483B Chinese patent medicine (Bezoar Qianliekang Turunda) for treating prostate disease and preparation method thereof |
| 01/18/2012 | CN101829077B Application of dicaffeoyl-quinic acid derivative in preparing drugs for treating mycoplasma infection diseases |
| 01/18/2012 | CN101695478B Tamsulosin hydrochloride sustained-release pellets and preparation method thereof |
| 01/18/2012 | CN101628080B Chinese medicinal capsule for tonifying kidney and strengthening yang |
| 01/17/2012 | US8097587 IGF-I protein variants for treating IGFBP-1-related disorders |
| 01/17/2012 | US8097585 Methods of treating inflammation by administration of heme oxygenase-1 and products of heme degradation |
| 01/17/2012 | CA2500873C Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same |
| 01/17/2012 | CA2485852C Agent for binding a plurality of c-reactive protein and their use in the treatment and prevention of tissue damage |
| 01/17/2012 | CA2441958C Il-28 polypeptides and polynucleotids |
| 01/17/2012 | CA2385456C 9-(piperazinylalkyl) carbazoles as bax-modulators |
| 01/17/2012 | CA2320371C Inotropic and diuretic effects of exendin and glp-1 |
| 01/12/2012 | WO2012006634A2 Prostate specific antigen (psa) peptide therapy |
| 01/12/2012 | WO2012005745A2 Compositions and methods for the inhibition of muscle contraction |
| 01/12/2012 | WO2012005340A1 Tablet containing ferric citrate |
| 01/12/2012 | WO2012005240A1 Bifidobacterium having activity of reducing amount of intestinal putrefacted substance |
| 01/12/2012 | WO2012005227A1 Tetrahydrocarboline derivative |
| 01/12/2012 | WO2012004900A1 Thienopyrimidine compounds |
| 01/12/2012 | WO2012004400A1 Novel spiroheterocyclic compounds as mglu5 antagonists |
| 01/12/2012 | WO2012004264A1 Solifenacin salts |
| 01/12/2012 | WO2012003810A1 Regulatory factor of foxp3 and regulatory t cells and use thereof |
| 01/12/2012 | WO2012003554A2 Compositions and methods for removal or destruction of amyloid fibril or amyloid adhesin comprising aggregates |
| 01/12/2012 | WO2011102657A3 Composition for percutaneous administration of tolterodine with improved skin permeation |
| 01/12/2012 | WO2011047173A3 Pharmaceutical compositions for oral administration |
| 01/12/2012 | US20120010295 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 01/12/2012 | US20120010294 Compositions and methods for the inhibition of muscle contraction |
| 01/12/2012 | US20120010265 Crystalline form of a 3-phenoxymethylpyrrolidine compound |
| 01/12/2012 | US20120010257 Modulators of cystic fibrosis transmembrane conductance regulator |
| 01/12/2012 | US20120010185 New pyridone derivates with mch antagonistic activity and medicaments comprising these compounds |
| 01/12/2012 | US20120009257 Galenical Formulations of a Fixed Dose Combination of Valsartan and Aliskiren |
| 01/12/2012 | US20120006748 Buffered compositions for dialysis |
| 01/12/2012 | CA2804107A1 Solifenacin salts |
| 01/12/2012 | CA2802216A1 Tetrahydrocarboline derivative |
| 01/12/2012 | CA2800930A1 Novel spiroheterocyclic compounds as mglu5 antagonists |
| 01/11/2012 | EP2404922A1 Quinoxaline compounds |